Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?

Editorial

P Marteau. Gut. 2006 Dec.

. 2006 Dec;55(12):1692-3.

doi: 10.1136/gut.2004.051458.

Abstract

Ecological treatment may be beneficial in patients with ulcerative colitis

Competing interests: None.

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.
Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'neil DA, Macfarlane GT. Furrie E, et al. Gut. 2005 Feb;54(2):242-9. doi: 10.1136/gut.2004.044834. Gut. 2005. PMID: 15647189 Free PMC article. Clinical Trial.

1. Furrie E, Macfarlane S, Kennedy A.et al Synbiotic therapy (Bifidobacterium longum/SynergyI) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trail. Gut 200554542–549. - PMC - PubMed
1. Sartor R B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 20041261620–1633. - PubMed
1. Tamboli C P, Caucheteux C, Cortot A.et al Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol 200317805–820. - PubMed
1. Ghosh S, van Heel D, Playford R J. Probiotics in inflammatory bowel disease: is it all gut flora modulation? Gut 200453620–622. - PMC - PubMed
1. Araki Y, Andoh A, Takizawa J.et alClostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium‐induced experimental colitis in rats. Int J Mol Med 200413577–580. - PubMed